No Data
No Data
Eli Lilly Alzheimer's Drug Set to Face Same Fate as Biogen's in U.K.: Report
S&P 500 Gains 1.4% in Weekly Rise, With Fuel From the Fed Greenlighting Rate Cuts
Johnson & Johnson Continues Gains for Eight Straight Sessions
J&J Reportedly Seeking Additional Support for Talc Bankruptcy Plan
Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets
U.S. to Restart Free COVID Test Program as Cases Spike